• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Market and Potential for Molecular Point of Care Diagnostics: Forecasts to 2018

$2,995.00 – $5,990.00

Clear
SKU: KLI5201690 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 245
  • Description
  • Table of Contents
  • Latest reports

Description

The Market and Potential for Molecular Point of Care Diagnostics

Molecular Point of Care is a budding field in medical diagnostics. Kalorama’s report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field.

To assess the opportunity, Kalorama’s report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products.   A good number of companies are producing or considering molecular diagnostic platforms and assays that are made for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The business focus for most of these companies is initially on infectious disease testing, in which rapid test results generate important data that physicians can utilize in making treatment decisions.

Included in the report is the following:

  • Company portraits for IVD Companies with POC MDX products.
  • Industry Estimates for Market Opportunity Based on Existing Markets, 2013-2018
  • Expenditure in Molecular POC
  • Microbiology Diagnostics Opportunities
  • Relevant Accords in Molecular
  • Purchases of Competitors with Near-Patient Solutions
  • Relevant Accords in POC
  • Analyst Conclusions on Future Trends

POC and Moleuclar are two of the strongest growth segments of the overall IVD industry.  These once were different industry segments, but this is no longer true.  Interest has grown in developing molecular diagnostic platforms that can be used in POC settings.   Indeed, as this new industry research report from Kalorama outlines, the emerging niche of rapid molecular POC testing has attracted almost $700 million in financing in just five years.

This report presents information derived from publicly available sources such as company reports and announcements, government reports and databases, medical organization reports, medical association announcements, and other publications. The assessment is based on the analyst’s industry knowledge combined with literature searches and discussions with industry pros and experts in the areas of POC testing, decentralized healthcare, and healthcare economics.

Almost 100 competitors involved in this industry are profiled in this report, including the following:

  • Abacus Diagnostica Oy
  • Access Bio, Inc.
  • Biocartis SA
  • BioFire Diagnostics, Inc.
  • bioMérieux sa
  • Cepheid
  • MBio Diagnostics, Inc.
  • Meridian Bioscience, Inc.
  • Micronics Inc. (A Sony Group Company)
  • Molbio Diagnostics Pvt. Ltd.
  • Nanosphere, Inc.
  • NetBio, Inc.
  • NorChip
  • OptiGene Ltd.
  • PositiveID Corporation
  • QIAGEN N.V
  • Wave 80 Biosciences
  • Xagenic Inc.
  • and many others

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Overview

Scope and Methodology

Market Overviews –Molecular Diagnostic and Point-of-Care Markets

Future Prospects –Molecular DIAGNOSTIC NEAR Patient/Point-of-Care Testing

CHAPTER TWO: INTRODUCTION

Evolution Towards Point-of-Care in Molecular Diagnostics – Market Drivers

Patent focused drivers

Medical/Healthcare related drivers

Technology drivers

Economic drivers

Other drivers

Overview of Companies Developing

Rapid Point-of-Care/Near-Patient Molecular Diagnostics Platforms

Point of View

CHAPTER THREE: ADVANCES IN MOLECULAR DIAGNOSTIC TECHNOLOGY

Molecular Diagnostic Technology Today

Advances and Emerging New Technologies to Make

POC Testing Possible

Advancing Molecular Diagnostic Technology for Limited Resource Settings – Non-Profit

Organizations

Bill & Melinda Gates Foundation (BMGF)

Foundation for Innovative New Diagnostics (FIND)

Program for Appropriate Technology in Health (PATH)

UNITAID

CHAPTER FOUR: DEALS – COMPANIES TARGETING MOLECULAR POINT-OF NEED/POINT-OF-CARE

Investments and Financing Agreements for Molecular Diagnostic Near-Patient/Point-of-Care

Companies

Agreements Between with Other Diagnostic Companies

Acquisitions of Molecular Diagnostic Near-Patient/Point-of-Care Companies

CHAPTER FIVE: CURRENT MARKETS

Molecular Diagnostics Market Overview

Point-of Care-Market Overview

Emerging Molecular Diagnostics Point-of-Care Market

CHAPTER SIX: MARKET OPPORTUNITIES

Healthcare Associated Infections

Influenza and Other Respiratory Tract Infections

Sexually Transmitted Diseases

Sepsis

Selected Infectious Diseases in Developing Countries

HIV/AIDS

Tuberculosis

Malaria Selected Other Diseases Found in Developing Countries

Other Infectious Diseases

Hematology/Oncology

Pharmacogenomic Tests

Risk of Thrombosis

Warfarin Sensitivity

CYP2C19 Genotyping

CHAPTER SEVEN: TECHNOLOGY DEVELOPMENTS AND PROGRESS TO DATE

Progress to Date and Current Trends

Issues and Hurdles Faced by Companies Developing Molecular Diagnostic POC Tests and

Platforms

Future Prospects

CHAPTER EIGHT: COMPANY PROFILES

Abacus Diagnostica Oy

Access Bio, Inc.

Ahram Biosystems, Inc.

Akers Biosciences, Inc.

Akonni Biosystems, Inc.

Alere Inc.

Amplino

Analytik Jena AG

Aquila Diagnostic Systems Inc.

Atlas Genetics Ltd

Atonomics A/S

Axxin

BD Diagnostics

Biocartis SA

BioFire Diagnostics, Inc.

bioMérieux sa

Canon U.S. Life Sciences

Cepheid

Coris BioConcept

Curetis AG

DestiNA Genomics Ltd.

Diagnostics for All (DFA)

Diagnostics for the Real World, Ltd.

DiaSorin S.p.A.

DiAssess Inc

DNA Electronics Ltd.

DxNA, LLC

Eiken Chemical Co., Ltd.

Enigma Diagnostics Limited

Epistem

Espira, Inc.

Focus Diagnostics, Inc.

GeneFluidics, Inc.

GenePOC Inc.

Great Basin Corporation

Hai Kang Life Corporation Limited

Hain Lifescience GmbH

HiberGene Diagnostics Ltd

iCubate, Inc.

Immunexpress Group

InstantLabs

Instrumentation Laboratory

IQuum, Inc.

Life Technologies Corporation

LiquiLume Diagnostics, Inc.

Lumora Ltd

Mast Group Ltd.

MBio Diagnostics, Inc.

Meridian Bioscience, Inc.

Mesa Tech International, Inc.

Metaara Medical Technologies Inc.

Micronics Inc. (A Sony Group Company)

Molbio Diagnostics Pvt. Ltd.

MP Biomedicals, LLC

MycroLab Diagnostics Pty Ltd.

Nanobiosym (NBS)

Nanobiosym Diagnostics (NBSDx)

NanoBioSys Inc.

NanoDetection Technology, Inc. (NDT)

NanoIVD, Inc.

Nanomix, Inc

Nanosphere, Inc.

NetBio, Inc.

NorChip

OptiGene Ltd.

PositiveID Corporation

QIAGEN N.V

QuantuMDx Group

Quidel Corporation

Rheonix Inc.

SA Scientific

Seegene, Inc.

Spartan Bioscience Inc.

STAT-Diagnostica

T2 Biosystems, Inc

Thermal Gradient, Inc.

TwistDx, Ltd. (Acquired by Alere)

Ustar Biotechnologies (Hangzhou) Ltd.

Veredus Laboratories Pte Ltd

Wave 80 Biosciences

Xagenic Inc.

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Next-Generation Sequencing in Latin AmericaThe Market for Medical Devices in EMEA: Forecasts to 2018
Scroll to top